Advertisement
Advertisement
U.S. Markets closed
S&P Futures
4,139.75 +7.50 (+0.18%) Dow Futures
34,061.00 -87.00 (-0.25%) Nasdaq Futures
12,515.50 +101.25 (+0.82%) Russell 2000 Futures
1,965.70 -2.70 (-0.14%) Crude Oil
77.05 +0.64 (+0.84%) Gold
1,968.30 +25.50 (+1.31%)
At close: 04:00PM EST
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 10.91 |
| Open | 10.74 |
| Bid | 11.15 x 800 |
| Ask | 11.25 x 1400 |
| Day's Range | 10.14 - 11.31 |
| 52 Week Range | 8.75 - 101.39 |
| Volume | |
| Avg. Volume | 6,826,378 |
| Market Cap | 849.079M |
| Beta (5Y Monthly) | 1.88 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.27 |
| Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 81.33 |
- Investor's Business Daily
Novavax Plans To Update Its Covid Shot — But Is NVAX Stock A Buy Today?
Is Novavax stock a buy as the company plans to update its Covid shot, in line with FDA experts' advice? Is NVAX stock a buy right now?
- Motley Fool
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
Novavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years. Initial gains came as investors bet on Novavax's chances of bringing a coronavirus vaccine to market; declines occurred after the vaccine entered the market later than rival products did. Now, as we start a new year, you might be wondering what to do about Novavax.
- Zacks
The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax
Pfizer/BioNTech, Moderna and Novavax are included in this Analyst Blog.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
